Home
ERAS

ERAS

Erasca Inc.

as of 12-09-2025 9:36am EST

$3.43

+$0.09

+2.69%

Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.

Chart Type:

Time Range:

Founded:	2018	Country:	United States
Employees:	N/A	City:	SAN DIEGO
Market Cap:	927.7M	IPO Year:	2021
Target Price:	$3.50	AVG Volume (30 days):	1.9M
Analyst Decision:	Buy	Number of Analysts:	6
Dividend Yield:	N/A	Dividend Payout Frequency:	N/A
EPS:	-0.45	EPS Growth:	N/A
52 Week Low/High:	$1.01 - $3.48	Next Earning Date:	11-12-2025
Revenue:	N/A	Revenue Growth:	N/A
Revenue Growth (this year):	N/A	Revenue Growth (next year):	N/A

AI-Powered ERAS Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 15 hours ago

AI Recommendation

hold

Model Accuracy: 76.35%

76.35%

Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

View Full ERAS Forecast & Prediction with Hourly Data

Compare ERAS vs Leading Stocks

See how ERAS stacks up against similar companies in the market

Share on Social Networks:

Tools & Resources

Enhance your trading experience with our free tools

Free ERAS Stock Widget

Embed our interactive stock ticker widget on your website for real-time updates.

Free Tool

Stock Alerts on Telegram

Get instant notifications, market insights, and expert analysis delivered to your phone.

Live Updates

Disclaimer

The information presented on this page, "ERAS Erasca Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.